Construction mediation and its hybridization: the case of the Hong Kong construction industry
Organization, Technology and Management in Construction: an International Journal · 2017
DOI: 10.1515/otmcj-2016-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organization, Technology and Management in Construction: an International Journal, 2017. Verfasst von Pui-Lam Ng und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In view of the sophisticated nature of construction disputes, specialized dispute resolution mechanisms are of pivotal importance to the satisfactory settlement between disputing parties. Among the various construction dispute resolution mechanisms, mediation has been increasingly gaining recognition and acceptance. Its hybrid, namely mediation–arbitration (med-arb), has also emerged and has started receiving attention and appreciation. With special reference to the construction industry practice in Hong Kong, a commentary on the respective merits and demerits of construction mediation and construction med-arb, as well as the ways forward, are presented in this article.
Zitieren
APA
Ng, P., & Banaitis, A. (2017). Construction mediation and its hybridization: the case of the Hong Kong construction industry. Organization, Technology and Management in Construction: an International Journal. https://doi.org/10.1515/otmcj-2016-0015
Vancouver
Ng P, Banaitis A. Construction mediation and its hybridization: the case of the Hong Kong construction industry. Organization, Technology and Management in Construction: an International Journal. 2017. doi:10.1515/otmcj-2016-0015
BibTeX
@article{Ng2017,
author = {Ng, Pui-Lam and Banaitis, Audrius},
title = {Construction mediation and its hybridization: the case of the Hong Kong construction industry},
journal = {Organization, Technology and Management in Construction: an International Journal},
year = {2017},
doi = {10.1515/otmcj-2016-0015}
}
EUVIMED